AI And CT Screening Will Expand COPD Care Worldwide
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
10 Aug 25
Updated
10 Aug 25
AnalystHighTarget's Fair Value
US$15.80
90.3% undervalued intrinsic discount10 Aug
US$1.54
1Y
-73.1%7D
-4.3%